A 50-year-old woman with new hypertension (136/86) and 10-year ASCVD risk 11% after lifestyle trial still above goal. Preferred initial drug class?ABeta-blockerBLoop diureticCThiazide-type diureticDACE inhibitorEARBCheck my answer